Mots-c 40mg

Sold out
€130.00

iVy Peptides MOTS-C Pen 40mg

The iVy Peptides MOTS-C Pen 40mg is supplied in a convenient pre-filled pen format for laboratory and scientific research, containing a 40mg MOTS-C formulation.

Product Specifications

Compound: MOTS-C (Mitochondrial-Derived Peptide)

Total Strength: 40mg

Format: Pre-filled Pen (Research Solution)

Storage: Refrigeration at 2–8°C is commonly specified for peptide solutions.

Keep refrigerated. Protect from direct light. Do not freeze.

Research Use Only

Package Contents

  • 1 × MOTS-C Pen (40mg)
  • 12x Needle Tips
  • Instruction Manual (Digital guide)

Important Notice

This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease. Purchasers are responsible for ensuring compliance with all applicable laws and regulations within their jurisdiction.

ℹ️ℹ️ℹ️ℹ️

What is MOTS-C?

MOTS-C is a naturally occurring mitochondrial-derived peptide that has attracted scientific interest for its potential involvement in cellular energy regulation, metabolic signalling, and mitochondrial function.

MOTS-C consists of 16 amino acids and is encoded within mitochondrial DNA. Researchers are investigating its relationship with energy metabolism, glucose regulation, cellular stress responses, and exercise-related adaptations.

Research conducted in laboratory and animal models has produced promising findings, although its safety and effectiveness for human use have not been established.

How It Works

  • Mitochondrial Function: Investigated for its potential role in mitochondrial signalling and cellular energy regulation.
  • Energy Metabolism: Studied for its involvement in metabolic pathways associated with energy production and utilisation.
  • AMPK Activation: Research suggests MOTS-C may influence AMPK signalling, an important pathway involved in cellular energy balance.
  • Glucose Metabolism: Preclinical studies are exploring its effects on glucose utilisation, insulin sensitivity, and metabolic regulation.
  • Exercise & Physical Performance: Animal research has investigated possible connections between MOTS-C, exercise adaptation, and physical endurance.
  • Cellular Ageing: Researchers are examining its potential involvement in age-related metabolic changes and cellular stress responses.
  • Metabolic Health: Ongoing research is investigating its role in metabolic homeostasis and mitochondrial communication.

Current Status

MOTS-C remains an investigational research peptide. It is not approved as a treatment for weight management, metabolic disorders, anti-ageing, athletic performance, or general wellness.

Although laboratory and animal studies have generated scientific interest, controlled clinical evidence involving administered MOTS-C in humans remains insufficient.

Further research is required to establish its safety, effectiveness, and appropriate applications.

Summary

MOTS-C 40mg represents an emerging area of scientific research focused on mitochondrial biology, cellular energy metabolism, metabolic signalling, and exercise-related cellular adaptations.

Its potential involvement in AMPK signalling, glucose metabolism, and mitochondrial function makes it a subject of ongoing preclinical investigation.

Further high-quality clinical studies are necessary to determine its safety, efficacy, and possible future applications.

#MOTSC #MOTSC40mg #IvyPeptides #Mitochondria #MetabolicResearch #CellularEnergy #AMPK #PeptideResearch #ResearchPeptides #40mg #ScientificResearch #Peptides